References
- Lilleyman J S. Acute lymphoblastic leukaemia. Eur J Cancer 1997; 33: 85–90
- Harrison C J. The detection and significance of chromosomal abnormalities in childhood acute lymphoblastic leukaemia. Blood Rev 2001; 15: 49–59
- Harrison C J. Acute lymphoblastic leukaemia. Best Pract Res Clin Haematol 2001; 14: 593–607
- Harris M B, Shuster J J, Carroll A, Look A T, Borowitz M J, Crist W M, et al. Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study. Blood 1992; 79: 3316–3324
- Moorman A V, Richards S M, Martineau M, Cheung K L, Robinson H M, Jalali G R, et al. United Kingdom Medical Research Council's Childhood Leukemia Working Party. Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia. Blood 2003; 102: 2756–2762
- Heerema N A, Sather H N, Sensel M G, Zhang T, Hutchinson R J, Nachman J B, et al. Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (>50 chromosomes). J Clin Oncol 2000; 18: 1876–1887
- Sutcliffe M J, Shuster J J, Sather H N, Camitta B M, Pullen J, Schultz K R, et al. High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: a Children's Oncology Group (COG) initiative. Leukemia 2005; 19: 734–740
- Raimondi S C, Pui C H, Hancock M L, Behm F G, Filatov L, Rivera G K. Heterogeneity of hyperdiploid (51 – 67) childhood acute lymphoblastic leukemia. Leukemia 1996; 10: 213–224
- Belkov V M, Krynetski E Y, Schuetz J D, Yanishevski Y, Masson E, Mathew S, et al. Reduced folate carrier expression in acute lymphoblastic leukemia: a mechanism for ploidy but not lineage differences in methotrexate accumulation. Blood 1999; 93: 1643–1650
- Moscow J A, Gong M, He R, Sgagias M K, Dixon K H, Anzick S L, et al. Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells. Cancer Res 1995; 55: 3790–3794
- Betts D R, Greiner J, Feldges A, Caflisch U, Niggli F K. Constitutional balanced chromosomal rearrangements and neoplasm in children. J Pediatr Hematol Oncol 2001; 23: 582–584
- Heerema N A, Raimondi S C, Anderson J R, Biegel J, Camitta B M, Cooley L D, et al. Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia. Genes Chromosomes Cancer 2007; 46: 684–693
- Gustafsson G, Schmiegelow K, Forestier E, Clausen N, Glomstein A, Jonmundsson G, et al. Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO). Leukemia 2000; 14: 2267–2275
- Zhang L, Taub J W, Williamson M, Wong S C, Hukku B, Pullen J, et al. Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: relationship to immunophenotype and ploidy. Clin Cancer Res 1998; 4: 2169–2177